Acadia Pharmaceuticals said on Monday that the U.S. Court of Appeals has confirmed the validity of its patent for Nuplazid, its drug for hallucinations and delusions associated with Parkinson's ...

An associate lawyer with Oyen Wiggs Green & Mutala LLP, Leslie advises Canadian manufacturers to be proactive rather than ...